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Abstract
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molecules, but that they are entirely lacking in cell signaling proteins. This fundamental distinction between
the functions of type 1 and type 2 synapses in the nervous system has far reaching implications for models of
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Introduction
Type 1 synapses, which were identified over fifty years ago
[1,2], mediate excitatory neurotransmission primarily through
glutamate. Accordingly, the most abundant ionotropic neuro-
transmitter receptors present at these synapses are a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-
methyl-D-aspartate (NMDA) type glutamate receptors, which
control local flux of sodium (Na+), potassium (K+) and the second
messenger calcium (Ca++) at the synapse. These glutamate
receptors are part of a larger complex, the PSD, whose detergent
insolubility makes it highly amenable to biochemical purification
and analysis. Over the past several decades, a multitude of studies
[3,4,5,6] have identified the various components of the PSD.
These include scaffolding proteins, such as PSD-95 [7], which
provide a central docking station for neurotransmitter receptors
and ion channels, and signaling components such as Ca++/
calmodulin-dependent protein kinase II (CaMKII) [8], calcineurin
[9] and SynGAP [10], which activate a wide variety of signal
transduction pathways in response to synaptic activity. These
signals both feed back onto the receptors to control synaptic
strength, and transduce signals from the synapse to the interior of
the cell to regulate transcription, translation and metabolism
[3,11].
Proteomic studies of type 1 synapses have revealed a surprising
degree of biochemical complexity: over 1,000 different proteins
have been identified as components of the PSD [5,12,13].
Although it is widely appreciated that many of these proteins
may be present in only a subset of excitatory synapses [6],
biochemical studies of the isolated NMDA receptor complex alone
reveals a structure of 2–3 MDa containing 186 distinct proteins
[13,14]. Furthermore, analysis of the cerebellar Purkinje cell/
parallel fiber PSD, which does not contain NMDA receptors, has
revealed that most proteins within this single excitatory synapse
type are involved in signal transduction [15]. The paradigm of the
synapse that has emerged from these studies is that of a complex
molecular machine composed of receptors and signaling molecules
that can convert chemical signals arriving at the synapse into the
cellular changes that underlie information processing, storage and
retrieval in the nervous system [3,11].
In contrast to the excitatory PSD, the biochemical complexity of
type 2, inhibitory synapses has largely eluded neuroscientists. It is
likely that the lack of information reflects both the relative rarity of
type 2 synapses in the brain (they comprise only ,5–15% of total
synapse number) and the difficulty of purifying these simple
structures by classical biochemical methods. Despite this, the
importance of inhibitory synaptic transmission is underscored by
recent studies of epilepsy, autism and schizophrenia, disorders
characterized by an imbalance in inhibitory and excitatory
neurotransmission [16,17].
Type 2 synapses use c-aminobutyric acid (GABA) or glycine as
their major neurotransmitter. Activated GABAA and glycine
receptors control neuronal excitability through regulated Cl- influx
at key subcellular domains. Specificity of distinct inhibitory
synapses is achieved in part through the pentameric structure of
GABAA receptors, which are assembled from a pool of 19 distinct
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subunits. These subunits confer differences in subcellular localiza-
tion, pharmacological properties, and Cl- conductance of the
receptor [18,19,20]. Each subunit contains a large intracellular
loop that contains sites for protein-protein interactions as well as
sites for phosphorylation [21], ubiquitination [22], and palmitoy-
lation [23,24].
The main synaptic scaffold at type 2 synapses has been
identified as gephyrin, which binds directly to both glycine and
GABA receptors [25]. Although several additional GABAA
receptor binding proteins have been identified [26], many of
these molecules are not localized specifically to synapses, and
function in receptor trafficking or post-translational modification.
It has also been shown in several studies that other neurotrans-
mitter receptors, such as NMDA [27,28], nicotinic acetylcholine
(nACh) [29] and dopamine (D5) [30] receptors, can be found in
the vicinity of GABAergic synapses, yet co-localization at the
synapse has been demonstrated only in the case of NMDA
receptors in hippocampal CA1 pyramidal neurons [27].
While it is known that posttranslational modulation of
glutamate receptors occurs in response to signaling events
generated at type 1 synapses and modulated by a diverse array
of PSD proteins, it is unknown whether such a diversity of
receptors and signaling molecules is similarly localized to type 2,
inhibitory synapses. Given that the structural distinction between
type 1 and type 2 synapses was reported over fifty years ago [31],
and that the biochemical nature of inhibitory synapses remains
unclear, we sought to determine whether type 2 synapses also
function in signal processing. To this end we conducted proteomic
studies of type 2 synaptic complexes isolated from mammalian
cortical pyramidal neurons.
Results
Generation of an Inhibitory Synapse Affinity Tag
Proteomic studies of mammalian synapses have relied heavily
on subcellular fractionation procedures that result in a PSD
fraction enriched in synaptic proteins [12,32,33,34]. While a
consensus list of nearly one thousand synapse associated proteins
has emerged from these studies [5,35,36,37], the distribution of
these proteins across specific synapse types remains unknown.
Since in this study we were interested in understanding the
biochemical properties of a specific class of cortical synapses, we
adopted the synaptic protein profiling strategy [15], which has
been developed to prepare biochemical fractions enriched in a
specific synaptic complex. In this strategy, a synapse affinity tag is
genetically expressed in a specific cell type of interest using
bacterial artificial chromosome (BAC) transgenesis. Biochemical
preparation of a synaptic fraction is followed by immunoaffinity
purification and mass spectrometry of the tagged synaptic protein
complex. In this way, non-synaptic proteins are depleted from the
preparation, and only the proteins present at the synapse type of
interest are enriched and identified by proteomic analysis.
For our studies of cortical inhibitory synaptic complexes by
synapse protein profiling, we generated an inhibitory synapse
affinity tag (VGABAARa1) by fusing an eGFP variant, Venus, to
the N-terminus of the GABAA receptor a1 subunit (GABAARa1)
(Figure 1A) because this subunit is abundantly expressed in the
cerebral cortex [19] and inserted into the majority of GABAA
receptors [38]. To test whether addition of the eGFP tag to the N-
terminus of the GABAAR a1 subunit does not disrupt its ability to
assemble into functional GABAA receptors, comparative analysis
of GABA elicited currents in Xenopus oocytes expressing receptors
assembled from the VGABAARa1 and the wildtype GABAARa1
were performed. As shown in Figure 1B, oocytes expressing
GABAARa1 in combination with the b1 or b2 and c2 subunits
show comparable current amplitudes as oocytes expressing the
Venus-tagged GABAARa1 subunit, indicating that VGABAARa1
is functionally indistinguishable from the endogenous GABAARa1
subunit. As expected, in the absence of any GABAARa1 subunit,
no GABA elicited currents were observed. Furthermore when
oocytes expressing GABAARb1 or b2 and GABAARc2 were
supplemented with a mixture of VGABAARa1 and wildtype
GABAARa1 subunits, no change of GABA currents was detected,
suggesting that the VGABAARa1 subunit does not interfere with
assembly and insertion of the wildtype GABAARa1 subunit.
To ensure that overexpression of the tagged subunit VGA-
BAARa1 does not interfere with the function of endogenous native
GABA receptors, we measured evoked inhibitory post-synaptic
currents (eIPSCs) by paired-pulse recordings in hippocampal
neuronal cultures infected with a lentivirus driving the expression
of either the wild-type GABAARa1 subunit or the VGABAARa1
subunit. Presynaptic neurons were stimulated with two consecutive
short pulses and postsynaptic neurons were voltage clamped to
record the amplitudes of the first and second eIPSCs (Figure 1C).
In control, non-infected cultures paired-pulse stimulation pro-
duced large first postsynaptic responses and smaller second
responses with low paired-pulse ratios (PPR = eIPSC2/
eIPSC1,0.6) characteristic of this type of neuronal preparation
[39] (Figure 1D–F). These responses were blocked by bicuculine, a
selective antagonist of GABAA receptors. Neuronal cultures
transduced with either the wildtype or venus-tagged receptor
subunits displayed comparable eIPSC amplitudes (Figure 1E) and
PPR ratios (Figure 1F). Taken together, these electrophysiological
data demonstrate that the VGABAARa1 subunits assemble into
functional GABAA receptors (oocytes) and that the function of
inhibitory synapses is not altered by the presence of the eGFP
affinity tag (neuronal cultures).
Transgenic Expression of VGABAARa1
To tag cortical inhibitory synapses in vivo, we generated BAC
transgenic mice expressing the VGABAARa1 subunit under the
control of the Otx1 gene locus because this BAC reproducibly
drives expression of transgenes in deep layer cortical pyramidal
neurons [40] and transgenic mice carrying this BAC display no
observable phenotype. Accordingly, VGABAARa1 was engi-
neered into the Otx1 BAC as described previously (www.gensat.
org) and Southern blot analysis used to confirm the correct
modification of the Otx1 BAC (Figure 2A), and the subsequent
insertion of the transgene into the mouse genome (Figure 2B). We
then analyzed whole cortical protein extract for the presence of the
fusion protein. Cortical extract from transgenic Otx1-VGA-
BAARa1 mice immunoblotted with an anti-GARa1 antibody
shows both the endogenous (GABAARa1) and fusion (VGA-
BAARa1) subunits at their respective sizes, while wild-type extract
contains only the endogenous subunit (Figure 2C).
To confirm correct cortical localization of the fusion protein,
VGABAARa1, we performed immunofluorescence confocal mi-
croscopy on fixed brain sections of transgenic and wild type mice
using an anti-GFP antibody. Low magnitude confocal images
show GFP immunoreactivity in cortical neurons of transgenic mice
(Figure 2D). The distribution of the fusion protein corresponds
with the expected distribution of endogenous GABAARa1 subunit
to cell bodies in cortical layers 5/6 and dendrites in layers 2/3,
with minimal staining in layer 4 [41]. Higher magnification
confocal images revealed GFP immunoreactivity for VGA-
BAARa1 in the perikarya of layer 5/6 pyramidal neurons of
transgenic mice while sections from the control Otx1-eGFP mice
revealed soluble eGFP, which fills the cell soma (Figure 2E).
The Biochemical Anatomy of Inhibitory Synapses
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VGABAARa1 Localizes to Inhibitory Synapses
To determine whether VGABAARa1 is present at inhibitory
synapses, an anti-GFP antibody was used to detect VGABAARa1
in cortical tissue. Using the DAB method to reveal GFP
immunoreactivity, VGABAARa1 was present in layer 5/6 cortical
pyramidal cell bodies and dendrites of transgenic but not wild type
mice (Figure 3A). We then performed immuno-electron micros-
copy to determine the subcellular localization of our transgene and
confirm its proper insertion into neuronal membranes (Figure 3B–
D). Immuno-electron microscopy demonstrated that VGA-
Figure 1. The inhibitory synapse affinity tag, Venus-GABAARa1, is functional in vitro. (A) Schematic of VGABAARa1, showing the N-terminal
fusion of an affinity tag, Venus. (B) Representative GABA-evoked currents (left) and current amplitude quantification (right) in voltage clamped
Xenopus oocytes after coinjection of the indicated GABR cRNA subunits. Values are expressed as mean 6 SEM; n = 5 oocytes per group (**p,0.01 t-
test). (C) Schematic of the patch and stimulation electrodes used for paired-pulse recordings in cultured hippocampal neurons transduced with
lentivirus encoding GABAARa1 (Lv-GARa1) or Venus-GABAARa1 (Lv-VGARa1) subunits. (D) Representative traces of GABAergic transmission in paired-
pulse recordings in non-infected neurons and in neurons infected with the indicated lentivirus. Control traces in the presence of bicuculine are shown
below each trace. (E) Quantification of the first eIPSC amplitudes and of the paired-pulse ratios obtained in the indicated neuronal cultures. Values are
expressed as mean 6 SEM; n = 729 recorded cells per group.
doi:10.1371/journal.pone.0039572.g001
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Figure 2. Transgenic expression of Venus-GABAARa1. (A) Strategy for Otx1 BAC modification with VGABAARa1. The red line shows the
Southern blot probe used in (B). Scale: 2 kb. (B) Correct incorporation of Venus-GABRA1 cDNA into the Otx1 BAC is shown by southern blotting. The
modified BAC (middle lane) contains an additional EcoR1 site. The right lane shows correct incorporation of the modified BAC into the mouse
genome. The transgenic mouse genome contains a wild-type copy of the Otx1 regulatory region as well as the modified Otx1-Venus-GABRA1 BAC. (C)
Cortical protein extract from wild type and Otx1-VGABAARa1 mice immunoblotted with anti-GABAARa1 antibody. Only the transgenic mouse
expresses the fusion version of the GABAARa1 subunit (top band). (D) VGABAARa1 expression in cortical layers 5 and 6 pyramidal neurons of Otx1-
VGABAARa1 mice is shown by GFP immunoreactivity. The fusion protein is localized to pyramidal cell soma in layers 5/6 and processes in layers 2/3.
Scale: 500 mm. (E) Immunofluorescence shows the colocalization of VGABAARa1 (green) and NeuN (red), a neuronal marker, in layers 5 and 6
pyramidal neurons of Otx1- VGABAARa1 transgenic mice (left). VGABAARa1 is mainly localized to the perikarya of the cell soma as well as dendrites. A
control Otx1 BAC transgenic mouse expresses soluble eGFP (right), which fills the cell soma. Scale: 100 mm. V: Venus. GAR: GABAA receptor.
doi:10.1371/journal.pone.0039572.g002
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BAARa1 was present at the cell membrane of pyramidal neurons
adjacent to axon terminals containing glutamic acid decarboxylase
(GAD), a presynaptic marker of type 2 GABAergic synapses.
Colocalization with GAD was seen at both the cell soma
(Figure 3B, C) and dendrites (Figure 3C) of layer 5/6 pyramidal
neurons.
To test whether VGABAARa1 is specifically targeted to
inhibitory synapses, a total cortical area of 614.6 square microns
was analyzed for the presence of VGABAARa1 at inhibitory and
excitatory synapses (see experimental procedures). Within this
area, 67 of the 134 inhibitory (symmetric) synapses were labeled by
VGABAARa1, whereas none of the 200 excitatory (asymmetric)
synapses were immunopositive for the fusion protein (Figure 3C).
Within each micrograph, an average of 54% of inhibitory synapses
were immunopositive for VGABAARa1, compared to 0% of the
excitatory synapses (Figure 3D). These data demonstrate the
Figure 3. Venus-GABAARa1 localizes specifically to inhibitory synapses. (A) Light microscopy of fixed saggital sections from wild type and
Otx1-VGABAARa1 transgenic mice treated with anti-GFP antibody and revealed with the DAB procedure. Transgenic, but not wild type mice express
the fusion protein in layer 5/6 cortical pyramidal neurons. The fusion protein localizes to cell bodies (arrows) and processes (arrowheads) in cortex.
Scale bars: 200 mm. (B) Immuno-electron microscopy shows VGABAARa1 expression (arrows) exclusively at inhibitory synapses by silver-intensified
immunogold labeling (SIG). Inhibitory terminals immunoreactive for GAD65/67 are revealed with the DAB procedure (white asterisks). Asymmetric
synapses (black asterisks) are immunonegative for both GAD and VGABAARa1. Scale: 500 nm. Cy: cytoplasm. Nu: nucleus. De: dendrite. V: Venus. GAR:
GABAA receptor. (C) Within a total cortical area of 614.6 square microns 67 of the 134 inhibitory (symmetric) synapses were labeled by VGABAARa1,
whereas none of the 200 excitatory (asymmetric) synapses were immunopositive for the fusion protein. (D) An average of 54% of inhibitory synapses
were immunopositive for VGABAARa1, compared to 0% of the excitatory synapses. The data are presented as average 6 SEM (t test).
doi:10.1371/journal.pone.0039572.g003
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specific targeting of VGABAARa1 to type 2, inhibitory synapses in
layer 5/6 cortical pyramidal neurons.
Biochemical Purification of an Inhibitory Synaptic Protein
Complex
Classical excitatory synapse preparations, based on sucrose or
Percoll gradients [42] have been optimized to isolate large,
detergent-insoluble protein complexes typical of the excitatory
PSD, and separate them from mitochondrial and reticular
fractions. We have previously developed a new method for
isolation of excitatory PSDs that, combined with affinity-purifica-
tion, results in greater recovery and purity necessary for mass
spectrometric analysis of single synapse types [15]. Inhibitory
synapses are likely to contain far fewer proteins and perhaps more
lipid than their excitatory counterparts given their relative
structural simplicity and elongated shape [43]. Therefore, to
accomplish the specific purification and enrichment of inhibitory
synaptic proteins we used our new purification method modified to
preserve inhibitory synaptic complexes intact but enable their
affinity-purification.
The ratio of detergent to protein/lipid is a critical determinant
in membrane solubilization; low ratios are necessary to purify large
segments of membrane incorporating intact protein complexes,
while increasing detergent will generate individual proteins in
detergent micelles [44]. The selection of detergent conditions was
conducted empirically, in order to maximize the recovery of intact
inhibitory synaptic proteins associated with VGABAARa1. In
accordance with published methods [45], we found that 0.1%
beta-octylglucopyranoside (b-OG) efficiently solubilized inhibitory
receptors, but failed to enrich the inhibitory synaptic complex in
high molecular weight fractions via gel filtration (Figure S1C). 3-
[3-cholamidopropyl-dimethylammonio]-l-propanesulfonate
(CHAPS) solubilized GABAA receptors [45,46,47], and inhibitory
synaptic complexes solubilized in 0.5% CHAPS were enriched in
high molecular weight fractions (Figure S1A). However, CHAPS
was less efficient than Triton X-100 in removing nonspecific
proteins during the subsequent affinity purification (Figure S1B).
Triton X-100 at a concentration of 0.5% is classically used to
extract excitatory PSDs and was used in our previous study of parallel
fiber/Purkinje cell PSDs. Our data also showed that this concentra-
tion of Triton X-100 dissociated gephyrin from GABAA receptors
and thus destroyed inhibitory synaptic complexes [15]. However, we
determined that mild solubilization with 0.1% Triton X-100 extracts
inhibitory synaptic complexes withminimum disruption (Figures4A,
S1), Following gel filtration, high molecular weight fractions were
enriched in markers of both inhibitory synapses (VGABAARa1,
endogenous GABAAR subunits and gephyrin) and excitatory
synapses, such as PSD95. Fractions eluting lower molecular weight
protein complexes were enriched in the endoplasmic reticulum
marker BIP and excluded from downstream affinity purification, as
they contain proteins involved in neurotransmitter receptor traffick-
ing in the interior of the cell.
Synaptic fractions were pooled (Figure 4A, red box), and subjected
toaffinitypurificationusingananti-eGFPantibody to isolate synaptic
complexes containing the VGABAARa1 fusion protein (Figure 4B).
To improve the specificity of our strategy, preparations were
performed in parallel on Otx1 BAC transgenic mice that express
soluble eGFP. In this way, proteins isolated as a result of adventitious
interactionswitheGFP, thebeadsor theantibodiescouldbeexcluded
from the analysis. The choice of beads used in the subsequent
immunoaffinity step of the preparation was also determined
empirically (Figure S1D). We found that anti-GFP coated epoxy
beads bound proteins nonspecifically, while Protein G beads did not
(Figure S1). This was likely due to binding of proteins other than the
monoclonal antibody to the epoxy beads, since epoxy beads coated
with a gel purified monoclonal antibody immunopurified fewer
nonspecific proteins (not shown). Finally, the size exclusion chroma-
tography used in the synaptic protein profiling strategy resulted in
substantially less material losses than classical methods of synapse
purification which rely on centrifugation through a density gradient
[15].Taken together, thesemodifications to the traditional excitatory
PSD preparation resulted ina procedure that is specifically tailored to
isolate large, inhibitorysynapticproteincomplexes thatareamenable
to downstream proteomic analysis.
As shown in Figure 4B, the synaptic fraction purified via
VGABAARa1 contained GABAARa1, b2/3 and c2 subunits,
demonstrating correct incorporation of the Venus-tagged subunit
into high-molecular weight structures containing endogenous
GABAA receptors in vivo. Gephyrin, the main scaffolding protein
for GABAA and glycine receptors [48,49], was also highly
enriched in this fraction. As expected from the specific targeting
of the VGABAARa1 affinity tag expression to a subset of deep
layer pyramidal cells, only a minor fraction of the endogenous
GABAA receptor subunits were recovered in the affinity purifica-
tion step. Notably, the primary scaffold of the excitatory PSD,
PSD95, was not present in these preparations. Furthermore, no
neurotransmitter receptors or scaffolding proteins (except for trace
amounts of gephyrin) were recovered using the same procedures to
isolate eGFP from control mice. Taken together, these data
demonstrate successful enrichment of high molecular weight
synaptic protein complexes from inhibitory synapses using a
combination of genetically engineered transgenic mice, subcellular
fractionation, and affinity purification of the VGABAARa1
synaptic tag.
Mass Spectrometry of Cortical Inhibitory Synaptic
Proteins
Studies of the synaptic proteome have typically utilized SDS-
PAGE to separate complex protein mixtures and to remove
detergents introduced during PSD extraction [12,13,35]. To avoid
the material losses associated with SDS-PAGE, and to improve
identification of low abundance proteins, we relied on filter-aided
sample preparation (FASP) [50] a recent innovation involving
microfiltration of Triton X-100 and on-filter digestion of proteins
followed by liquid chromatography tandem mass spectrometry
(LC-MS/MS) [51]. This departure from SDS-PAGE separation
was a crucial modification to our previous strategy of synaptic
protein profiling, as it facilitated retention and identification of low
abundance proteins in our complex.
Proteins purified via VGABAARa1 from two replicate exper-
iments were identified using the Global Proteome Machine (GPM)
database search program X!Tandem (http://ppp.thegpm.org/
tandem/ppp.html) [52] to yield a highly specific cohort of
inhibitory synaptic proteins with an expectation value cutoff score
of E = 1024 (Table 1, Table S1 and Figure S2). This expectation
value cutoff represents the probability that the identification was
random 2 i.e., a probability of #1 part in 10,000. This confidence
level was independently confirmed using the target decoy strategy,
which is derived from searching a database containing the
sequences of all mouse proteins together with their artificially
reversed sequences [53]. Although the reversed sequence database
has the same size and amino acid distribution as the normal mouse
protein database, it is devoid of any natural protein sequences, and
provided an independent method for determining the likelihood of
false positive identifications. In the present analyses, no reversed
sequence proteins were detected below the E = 1024 expectation
value cutoff.
The Biochemical Anatomy of Inhibitory Synapses
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39572
To confirm the specificity of the proteins identified by MS, only
those proteins unequivocally identified in the VGABAARa1
pullout and not in the eGFP pullouts were considered to be
specific to the inhibitory synaptic complex. For example, peptide
GDDNAVTGVTK, from GABAARb2 was present only in the
material purified via VGARa1, and not found at the equivalent
reversed phase HPLC retention time in the sample purified via
soluble eGFP (Figure 5A). Similar mass chromatograms to those
shown in Figure 5A (i.e., chromatograms showing the trace of a
peptide species from a given protein with its mass specified to
,10 ppm) were compared between the VGABAARa1 pullouts
and controls for every peptide from every putative inhibitory
synapse protein (Table S1 and Figure S2). Our analysis yielded a
highly specific cohort of inhibitory synaptic proteins (Figure 5B
and Table 1).
The first major class of proteins isolated via tagged type 2
inhibitory synapses was GABAA receptors. Eleven subunits were
specifically identified, including GABAAR a125, b123, c122,
and d. These subunits are expressed in the cerebral cortex [38],
and likely comprise a mixture of high- and low-abundance
receptors [19,54]. The variety of subunits immunopurified via
VGABAARa1 is consistent with the widespread distribution of the
GABAARa1 subunit to the majority of cortical inhibitory synapses
[38,55]. The second major class of proteins identified consists of
scaffolding and adhesion molecules. Included in this group are
gephyrin, the main scaffold for inhibitory synapses, and collybistin
[56], a known gephyrin binding protein. Mass spectrometry also
identified two postsynaptic cell-adhesion molecules previously
shown to localize to inhibitory synapses, neuroligin 2 (Nlgn2) [57]
and neuroligin 3 (Nlgn3) [58]. The pre-synaptic protein neurexin 1
(Nxn1), which forms trans-synaptic adhesion complexes by
binding to neuroligins, was also identified in our analysis. Finally,
mass spectrometry identified two proteins whose function at
synapses is less clear: neurobeachin (Nbea) and lipoma HMGIC
fusion partner-like 4 (Lhfpl4). Studies of Nbea mutant mice have
shown that this protein is preferentially involved in the formation
and function of inhibitory synapses, and that it controls the level of
expression of several proteins, including the neuroligins, at the
synapse [59]. This is consistent with electron microscopic studies
showing neurobeachin association with Golgi stacks and internal
membranes in Purkinje neurons, and with the postsynaptic
membranes of inhibitory synapses onto granule cell neurons
[60]. The presence of a signal sequence and four highly conserved
transmembrane domains in Lhfpl4 is also consistent with its
presence in the synaptic membrane. A schematic of one possible
distribution of the inhibitory protein complex is shown in
Figure 5B. It is noteworthy that PSD95, CaMKII and Nlgn1,
abundant scaffolding, signaling and adhesion proteins present in
the synaptic fraction (Figure 4, Figure 6A) and characteristic of
excitatory synapses, were absent from the affinity purified
inhibitory synaptic complexes.
Proteins Identified by Mass Spectrometry are Present at
Inhibitory Synapses
The identification of Nlgns 2 and 3 in inhibitory synaptic
complexes isolated from deep layer cortical pyramidal cells is of
particular interest because of their association with autism
spectrum disorders [17]. To confirm the mass spectrometry
results, we performed western blots of affinity purified VGA-
BAARa1 synaptic complexes (Figure 6A). Nlgns 2 and 3 were
Figure 4. Biochemical purification of a tagged inhibitory synaptic protein complex. (A) Immunoblotting of various proteins shows that
detergent solubilized protein extract S3 was enriched in both inhibitory (VGABAARa1, GABAARa1, GABAARb2/3, GABAARc2) and excitatory (GluR2,
PSD95) synaptic proteins, as well as mitochondria (COx). Gel filtration of fraction S3 enabled enrichment of synaptic protein complexes relative to
intracellular proteins, as shown by the specific exclusion of the endoplasmic reticulum marker BIP, from the high molecular weight fractions (6–10).
Protein concentration of each fraction was measured (top), and the void volume determined by the elution of Blue Dextran (2000 kDa). Identical
results were obtained for endogenous proteins in fractions prepared from wildtype or Otx1-eGFP cortices (not shown). (B) Fractions 6–10 (red box in
A) from Otx1-VGABAARa1 or Otx1-eGFP control were pooled and subject to co-immunopurification using an anti-eGFP antibody. Immunoblotting
confirmed the specific presence of inhibitory synaptic proteins (VGABAARa1, GABAARa1, GABAARb2/3, GABAARc2) and the absence of excitatory
synaptic (GluR2, PSD95) and mitochondrial (COx) proteins in the material immunopurified via VGABAARa1. Only soluble eGFP was detected in the
control sample. IN: Input. FT: Flow-through. IP: Immunoprecipitate. V: Venus. GAR: GABAA receptor. Further biochemical experimental results are
presented in Figure S1.
doi:10.1371/journal.pone.0039572.g004
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readily detected in the inhibitory synapse preparations, as was the
a2 subunit of the GABAA receptor. As expected, Nlgn1 and
CaMKII were not detected in the inhibitory synapse preparation.
Furthermore, none of these proteins were detectable in western
blots of control preparations from animals expressing soluble
eGFP in the same population of cortical neurons.
To examine the distribution of selected proteins identified in our
analysis, we performed double immunofluorescence studies
(Figure 6). Gephyrin and VGABAARa1 co-localization was seen
at the perimeter of the soma and axon initial segment (Figure 6B),
which reflect plasmalemmal clustering, whereas PSD95 was
markedly absent from the pyramidal cell soma, and displayed a
punctate staining that did not co-localize with VGABAARa1
(Figure 6C). As expected, GABAAR b2/3 and Nlgn2 were also
evident in puncta double labeled by VGABAARa1, confirming
their presence at type 2 synapses (Figures 6D, E). Nlgn3 was also
present in puncta on the cell surface that co-localized with
VGABAARa1 (Figure 6F), although in contrast to Nlgn2 puncta,
which appeared evenly distributed over the soma in deep layer
pyramidal cells, Nlgn3 puncta were present preferentially at the
base of apical dendrites. In addition, Nlgn3 appeared to be much
less abundant than Nlgn2, as evidenced in the immunofluores-
cence staining as well as our analyses by western blot (Figure 6A)
and mass spectrometry (Table 1 and Figure S2). This interesting
distinction between the subcellular distributions of neuroligins 2
and 3 in the cerebral cortex suggests that they may localize to
distinct classes of inhibitory synapses. Indeed, previous work has
demonstrated that the majority of gephyrin-immunoreactive
synapses in the hippocampus contain Nlgn2, while only approx-
imately half contain Nlgn3 [61]. Taken together, these results
demonstrate that the inhibitory synapse proteomics strategy used
here is sufficiently sensitive for identification of molecules present
at even a small subset of type 2 synapses tagged by VGABAARa1.
Discussion
Functional and biochemical studies of type 1 excitatory synapses
have established the current paradigm of the synapse as a complex
subcellular machine that upon binding of neurotransmitters to
receptors located on the postsynaptic membrane, regulates the
influx of Na+ that triggers the depolarization of that cell, and
transduces local Ca2+ influx into a wide variety of signals that are
critical for synaptic plasticity, learning and memory [3,6,62]. In
contrast to this model, we report here that postsynaptic complexes
isolated from type 2, cortical inhibitory synapses are elegantly
simple: they contain neurotransmitter receptors mediating fast
inhibitory neurotransmission, scaffolding molecules required to
organize these receptors, and adhesion molecules that bind the
postsynaptic specialization to presynaptic sites of neurotransmitter
release. Despite the many signaling components identified in
similar studies of type 1, asymmetric, excitatory synapses, the only
protein identified in the type 2 synaptic complex preparation with
domains characteristic of signal transduction proteins is the
RhoGEF, collybistin. Significantly, the GDP-GTP exchange
activity of collybistin is thought to participate intracellularly to
regulate gephyrin clustering, not to transduce signals from the
synapse to the cell interior [63]. This idea is consistent with recent
studies demonstrating roles for non-synaptic GABAA receptor
Table 1. Inhibitory synaptic proteins identified by mass spectrometry.
Dataset Replicate
Protein name Ensembl protein ID Mr (kD) GPM E value
Total
peptide
no.
Unique
peptide
no. Functional annotation
GABAAR b2 00000007797 54.6 10
2158 15 7 MS/MS Neurotransmitter receptor subunit
GABAAR b1 00000031122 54.1 10
2156 15 9 MS/MS Neurotransmitter receptor subunit
GABAAR b3 00000038051 54.1 10
2115 12 5 MS/MS Neurotransmitter receptor subunit
Neuroligin 2 00000053097 90.9 102111 15 13 MS/MS Postsynaptic cell-adhesion molecule
GABAAR a1 00000020707 51.7 10
295 13 9 MS/MS Neurotransmitter receptor subunit
Gephyrin 00000054064 83.2 10286 12 12 MS/MS Postsynaptic scaffold protein
GABAAR c2 00000063812 55.1 10
265 10 9 MS/MS Neurotransmitter receptor subunit
GABAAR a3 00000062638 55.4 10
245 5 4 MS/MS Neurotransmitter receptor subunit
Neuroligin 3 00000066304 91.1 10245 5 3 MS/MS Postsynaptic cell-adhesion molecule
Neurobeachin 00000029374 326.7 10240 6 6 MS Postsynaptic cell-adhesion molecule
GABAAR a2 00000000572 51.1 10
237 5 3 MS/MS Neurotransmitter receptor subunit
GABAAR a4 00000031121 60.8 10
237 5 5 MS/MS Neurotransmitter receptor subunit
GABAAR a5 00000063276 52.2 10
232 4 1 MS/MS Neurotransmitter receptor subunit
Neurexin I 00000057294 129.6 10221 4 4 MS Presynaptic cell-adhesion molecule
GABAAR c1 00000031119 53.4 10
217 5 4 MS Neurotransmitter receptor subunit
LHFPL4 00000061172 27.3 1028 4 4 MS/MS Integral membrane protein
GABAAR d 00000030925 50.5 10
27 2 2 MS Neurotransmitter receptor subunit
Collybistin 00000085403 58.2 1026 1 1 MS Gephyrin binding protein
Proteins were purified via VGABAARa1 or eGFP and identified by LC-MS/MS. Two replicate datasets were analyzed using the GPM Database and those proteins identified
in the eGFP controls were excluded from the list. Proteins present in the dataset were confirmed to be present in the replicate by either MS or MS/MS, as indicated. GPM
E value is the probability that an assignment occurs by chance. Total peptide number is the total number of peptides that match a given protein. When more than one
homologue is reported, unique peptide no. corresponds to the number of peptide matches that are unique to the homologue.
doi:10.1371/journal.pone.0039572.t001
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binding proteins and other neurotransmitter receptors in the
modulation of inhibitory synapses. For example, GABARAP [64],
GODZ [24], and PLIC-1 [65] bind directly to GABAA receptors
and regulate their insertion at synapses, yet they are situated away
from the postsynaptic membrane within trafficking structures such
as the Golgi apparatus and ER. Although this class of proteins
would not have been recovered in our study because we
specifically removed trafficking complexes by size exclusion
chromatography, they provide important opportunities for intra-
cellular regulation of inhibitory synapse function. Recent studies
demonstrating that activation of alpha7-nicotinic acetylcholine
receptors (a7-nAchR) enhances GABAergic synaptic strength are
also of interest, since they indicate that additional regulation of
type 2 synapses may occur through signals from perisynaptically
localized receptors [29]. Thus, our data suggest a fundamental
functional distinction between excitatory and inhibitory synapses
in the cerebral cortex: we propose that type 2 synapses are
biochemically organized exclusively to control Cl- influx at specific
domains in the cell to regulate neuronal excitability.
The model of the inhibitory synapse that we propose is
supported by several lines of evidence. First, recent studies of
cortical synapses using focused ion beam milling and scanning
electron microscopy suggest that the minimal electron density
apparent at type 2 synapses may be composed only of the
scaffolding proteins required to organize inhibitory receptors and
adhesion molecules required to maintain synaptic contact [35,43].
Second, we have used even gentler biochemical methods (e.g.
solubilization using 0.1% instead of 0.521.0% Triton X-100) than
those used previously to characterize the other synaptic complexes
[5,35] and have obtained high confidence scores with sensitive
Figure 5. Mass spectrometry identifies proteins present at tagged inhibitory synapses. (A) All peptides were evaluated individually, for
their presence or absence in the sample isolated via VGABAARa1 or eGFP, using information from peptide fragmentation spectrum (MS/MS), peptide
mass spectrum (MS), and peptide retention time in extracted ion chromatogram. An example is shown for peptide, GDDNAVTGTK, from GABAARb2.
V: Venus. GAR: GABAA receptor. (B) Schematic representation of the cortical inhibitory synaptic protein complex. These synapses contain a multitude
of inhibitory receptors, as well as cell signaling and adhesion proteins, but are entirely lacking in cell signaling molecules. The localization of LHFPL4
and Neurobeachin is hypothetical. Complete information on each peptide is in Table 1 and Figure S2 and Table S1.
doi:10.1371/journal.pone.0039572.g005
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mass spectrometry methods to identify proteins present at affinity-
tagged synapses. Perhaps the most compelling argument in
support of the biochemical anatomy of the inhibitory synapse
that we present here is the simple fact that Cl- has not been
demonstrated to serve as a second messenger for signal transduc-
tion. Thus, in contrast to the PSD of excitatory synapses, which is
organized for local activation of a variety of signal transduction
pathways, there is no biochemical principle for assembly of
signaling proteins at the inhibitory synapse because GABAA
receptors do not gate the influx of a known second messenger.
However, the proteomic composition of inhibitory synapses in
early development is an interesting area of further study, given that
GABA induced Cl- flux is outward in developing neurons [66].
Consideration of the biochemical nature of the inhibitory
synapse that we present here has broad implications for
understanding of synaptic plasticity, neural circuit adaptation,
and behavior. A cardinal prediction of this model is that plasticity
of type 2 synapses will involve exclusively mechanisms that operate
in the presynaptic terminal, or that are mediated by pathways
triggered by intracellular signals that do originate at the synapse
itself. Consistent with this idea, well characterized forms of short
term plasticity at GABAergic synapses involve presynaptic
mechanisms modulated by retrograde signals produced by
neighboring excitatory synapses, or in response to release of
Ca2+ from intracellular stores [67]. Although the regulation of
homeostatic plasticity in inhibitory circuits is currently under
investigation [68], our results suggest that the mechanisms
responsible for longer term changes in inhibitory synapses will
be triggered by signaling pathways distal to the synapse that
regulate the synthesis, trafficking, assembly and functional
characteristics of GABAA receptors [69]. Given the critical role
of homeostatic regulation in experience dependent plasticity, the
importance of synaptic modulation at type 2 synapses for
maintaining the balance of excitation and inhibition, and the
relevance of these mechanisms to neurological disorders, it seems
evident that the fundamental biochemical distinction between
excitatory and inhibitory synapses revealed here will inform future
efforts to understand detailed mechanisms of CNS function and
dysfunction.
Methods
Detailed Experimental Procedures can be Found in Text
S1
Animals. The cDNA encoding GABRA1 together with the
39UTR was amplified from cortical RNA, and placed in frame
with a preprotrypsin signal sequence and Venus prior to insertion
into the Otx1 BAC [40]. BAC transgenic mice were bred on the
FVB background and littermates were used as wild-type controls.
All experiments using animals were performed according to
Figure 6. Proteins identified by mass spectrometry are present
at inhibitory synapses. (A) Immunoblotting of several proteins
identified by mass spectrometry confirmed their presence in immuno-
purified inhibitory synapses. GABAARa2, neuroligin2 and neuroligin3 are
present, while excitatory markers neuroligin1 and homer are absent
from VGABAARa1-tagged inhibitory synapses. The abundant signaling
molecule CaMKII is also absent. (B-F) Immunofluorescence studies
confirm the colocalization of several proteins identified by mass
spectrometry with VGABAARa1. Gephyrin is localized to inhibitory
synapses on both the cell soma and axon initial segment (B), while
PSD95 is markedly absent (C). GABAARb2/3 (D), Nlgn2 (E) and Nlgn3 (F)
also colocalize with VGABAARa1 in cortical pyramidal neurons. Scale:
10 mm. V: Venus. GAR: GABAA receptor.
doi:10.1371/journal.pone.0039572.g006
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protocols approved by the Institutional Animal Care and Use
Committee at The Rockefeller University.
Two-Electrode Voltage-Clamp Recordings of Xenopus
Oocytes
cDNA encoding for the Venus-GABRA1 subunit was subcloned
into the pCS2A plasmid for oocyte expression. cDNA clones of the
rat subunits GABRA1, GABRB1, GABRB2, GABRG2 in pGEMHE
plasmid were a generous gift from Dr. Myles Akabas (Albert
Einstein Institute, New York). All clones were in vitro transcribed
with T7 or SP6 RNA polymerases (mMESSAGE mMACHINE,
Ambion, Austin, TX) as described [70]. Oocytes were surgically
removed and prepared as described [71]. Each oocyte was injected
with 20 nl of a cRNA mix containing 1 ng of each subunit.
Macroscopic currents were recorded 2 days after injection with a
GeneClamp 500 B amplifier (Axon Instruments) using a two-
electrode voltage clamp with active ground configuration.
Lentivirus Production and Paired-Pulse Recordings in
Primary Neuronal Cultures
Recombinant lentiviral vectors were prepared using transient
transfection of HEK293T cells as described [39]. Dissociated
hippocampal cultures were prepared from embryonic day 19 rat
embryos and prepared as described [39]. The influence of
VGABAARa1 subunit on synaptic activity was analyzed by
quantification of evoked inhibitory postsynaptic currents (eIPSCs)
with paired-pulse stimulation in hippocampal neuron cultures as
previous reported [39]. The bath solution contained: 105 mM
NaCl, 3 mM KCl, 10 mM HEPES, 5 mM glucose, 2 mM CaCl2
and 1 mM MgCl2. The recording pipette solution contained:
3 mM NaCl, 90 mM KCl, 5 mM EGTA, 5 mM HEPES, 5 mM
glucose, 0.5 mM CaCl2 and 4 mM MgCl2. eIPSCs were isolated
by blocking glutamatergic input (CNQX, 10 mM; DL-APV,
50 mM). Inverted eIPSCs were induced with a stimulation pipette
similar to the recording pipette in close proximity to presynaptic
neurons. To confirm recorded eIPSCs, bicuculline was to block
the evoked GABAergic currents. The stimulation rate ensured
recovery of presynaptic terminals from previous stimulation
(intersweep interval 30 s). Data acquisition and analysis were
performed with software Patchmaster and Fitmaster (HEKA
Electronics), and with Mini Analysis program (Synaptosoft Inc).
Immunofluorescence and Confocal Laser Scanning
Microscopy
For images taken at lower magnification sections were prepared
according to previously published protocols [72]. Mice were
transcardially perfused with 4% paraformaldehyde in PBS,
postfixed, and equilibrated in 30% sucrose. Serial free-floating
coronal sections (35 mm) through the cortex were processed for
immunofluorescence. For images taken at higher magnification,
mice were euthanized by CO2 asphyxiation and fresh frozen
sections (14 mm) were prepared using a cryostat. Slide-mounted
sections were fixed in 4% paraformaldehyde and double or triple
immunofluorescence staining was performed [73]. The sections
were analyzed by confocal laser scanning microscopy (Zeiss LSM
510) using Image J software (NIH).
Immuno-Electron Microscopy
Double immuno-electron microscopy was performed to deter-
mine whether VGARa1 occur postsynaptic to GABAergic axon
terminals, latter of which were identified by the presence of the
GABA-synthesizing enzyme, glutamic acid decarboxylase (GAD).
Double labeling used 3,3-diaminobenzidine HCl (DAB) and silver-
intensified colloidal gold (SIG) as immunolabels [74]. Brains of
WT and Otx1-VGARa1 transgenic mice were fixed by transcar-
dial perfusion of 0.1% glutaraldehyde, mixed with 4.0% parafor-
maldehyde in 0.1 M phosphate buffer (PB, pH 7.4). Layer 5/6
pyramidal neurons were identified by both position and immuno-
reactivity for the transgene. Images used for the Figure were
captured digitally using a Hamamatsu CCD camera attached to a
JEOL 1200XL electron microscope at a magnification of 40,000x
and spanning an area of 29 mm2.
Preparation of Synaptic Protein Complexes and Affinity
Purification
Five cortices from adult mice were used for the preparation of a
crude synaptosome fraction based on previously published
protocols [42]. The solubilized fraction was separated by gravity
flow on a gel-filtration column (Sephacryl S1000 Superfine, GE
Healthcare). Pooled fractions from the column were used for
affinity-purification of tagged inhibitory synaptic protein complex-
es using anti-GFP conjugated Dynabeads Protein G beads (Dynal,
Oslo).
Mass Spectrometry
Mass spectrometry analysis was performed on proteins affinity
isolated via VGARa1 (tagged sample) or eGFP (control sample)
and digested using the ‘‘FASP II’’ on-membrane digestion
protocol [50] using an LTQ-Orbitrap XL mass spectrometer.
Protein identification was carried out by searching a mouse
protein sequence database using The Global Proteome Machine
(GPM) database search program X!Tandem (http://ppp.thegpm.
org/tandem/ppp.html) [52]. Proteins that were uniquely affinity
isolated via VGARa1 were then determined by subtracting
proteins that were immunoisolated via eGFP.
Statistical Analysis
Unpaired two-tailed Student’s t tests were used for analyzing the
data. Results are presented as means 6 SEM.
Supporting Information
Figure S1 Biochemical enrichment of an inhibitory
synaptic protein complex. (A) CHAPS solubilize intact
inhibitory synapses, as shown by enrichment of inhibitory synaptic
proteins in high molecular weight fractions (6–10) following size
exclusion chromatography. (B) 0.5% CHAPS is less efficient than
Triton X-100 in clearing contaminant proteins during an affinity
purification step. Input material is from Otx1-eGFP cortices
fractions 6–10. (C) Solubilization of cortical synapses with 1% b-
octylglucoside (b-OG) disrupts inhibitory synaptic protein com-
plexes. Inhibitory GABA receptor subunits elute in low-molecular
weight fractions. (D) Epoxy-coated magnetic beads bind nonspe-
cific proteins during an affinity purification step, compared to
Protein G coated beads. Beads were coupled to a monoclonal anti-
eGFP antibody. Affinity purification from control Otx1-GFP mice
using epoxy-beads resulted in contaminating proteins present in
the eluate, which included PSD95, GABAARa1 and b2/3.
(TIF)
Figure S2 Mass spectrometry identifies proteins pres-
ent at tagged inhibitory synapses. (A-Q) All peptides were
evaluated individually, for their presence or absence in the sample
isolated via VGABAARa1 or eGFP, using information from
peptide fragmentation spectrum (MS/MS), peptide mass spectrum
(MS – not shown), and peptide retention time in extracted ion
chromatogram. An example peptide is shown for each protein
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listed in Table 1. For cases in which MS/MS data was only
available for one of the two data sets (VGABAARa1 or
VGABAARa1 Replicate), both chromatograms are shown. In
cases in which the control chromatogram (eGFP IP) contained a
peak at the equivalent retention time, the corresponding MS (not
shown) was analyzed to determine whether the peak contained the
equivalent or background peptide.
(PDF)
Table S1 Detailed analysis of peptides identified by LC-
MS/MS. (A) Proteins were identified by the GPM protein
sequence database search program X!Tandem using data from the
LC/MS/MS experiments. Ensemble ID is the protein accession
number in the Ensemble Mouse database. Paralogues sharing
some of the indicated peptides are given in brackets. (B) Peptide
sequences observed in the LC/MS/MS experiment. The symbol
‘‘*’’ indicates peptide sequences that also appear in protein
paralogues. In cases where the peptides are modified, italic Q
stands for Pyroglutamate formed at N-terminal Gln, italic M for
oxidized Met, italic W for oxidized Trp and italic A for acetylated
N terminal Ala. Representative mass chromatograms and MS/MS
data for bold format peptides are show in Figure 4 and Figure S3.
(C) Experimental peptide molecular masses. (D) Experimental
peptide molecular masses – calculated peptide molecular masses.
(E) Charge state of the observed peptide ions. (F) Mass to charge
ratio of the observed peptide ions. (G) Experimental evidence for
peptides’ presence in VGABAARa1 sample. MSMS stands for the
peptide being identified via its fragmentation spectrum. MS stands
for evidence of the presence of a peptide via its accurately
measured mass. (H) Experimental evidence for peptides’ presence
in replicate VGABAARa1 sample and GFP control sample. The
symbol ‘-’ indicates non-observation of the peptide.
(PDF)
Text S1 Detailed experimental procedures and sup-
porting information references.
(DOCX)
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